BioCurity and Venture Partners at the University of Colorado Announcement

BioCurity Pharmaceuticals is pleased to announce that Venture Partners at the University of Colorado - Boulder will be providing strategic support to BioCurity Pharmaceuticals in the development and commercialization of their supportive care oncology drug.

Venture Partners (www.colorado.edu/venturepartners) works with their business and entrepreneurial networks, as well as top CU scientists and researchers, to bring to market groundbreaking technology for maximum economic and social impact globally. Venture Partners' alliance with the University of Colorado Cancer Center is a future resource for clinical trials and collaborative oncology research for BioCurity.

Management at BioCurity looks forward to pursuing opportunities in 2024 with CU Venture Partners' strategic support.

University of Colorado - Boulder